A pilot randomized trial of nebulized amphotericin in patients with allergic bronchopulmonary aspergillosis

References

• Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis JF, Guleria R, Moss R, et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy 2013;43:850–873
   PubMed Web of Science ®Google Scholar
• Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax 2015;70:270–277
   PubMed Web of Science ®Google Scholar
• Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis 2009;13:936–944
   PubMed Web of Science ®Google Scholar
• Maturu VN, Agarwal R. Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis. Clin Exp Allergy 2015;45:1765–1778
   PubMed Web of Science ®Google Scholar
• Moss RB. Allergic bronchopulmonary aspergillosis. Clin Rev Allergy Immunol 2002;23:87–104
   PubMed Web of Science ®Google Scholar
• Moss RB. Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis. Curr Opin Pulm Med 2010;16:598–603
   PubMed Web of Science ®Google Scholar
• Dhooria S, Agarwal R. Diagnosis of allergic bronchopulmonary aspergillosis: a case-based approach. Future Microbiol 2014;9:1195–1208
   PubMed Web of Science ®Google Scholar
• Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009;135:805–826
   PubMed Web of Science ®Google Scholar
• Denning DW, Pleuvry A, Cole DC. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol 2013;51:361–370
   PubMed Web of Science ®Google Scholar
• Agarwal R, Denning DW, Chakrabarti A. Estimation of the burden of chronic and allergic pulmonary aspergillosis in India. PLoS One 2014;9:e114745
   PubMed Web of Science ®Google Scholar
• Hinson KF, Moon AJ, Plummer NS. Broncho-pulmonary aspergillosis: a review and a report of eight new cases. Thorax 1952;7:317–333
   PubMed Web of Science ®Google Scholar
• Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest 2006;130:442–428
   PubMed Web of Science ®Google Scholar
• Patterson R, Greenberger PA, Halwig JM, Liotta JL, Roberts M. Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 1986;146:916–918
   PubMedGoogle Scholar
• Agarwal R, Chakrabarti A. Clinical manifestations and natural history of allergic bronchopulmonary aspergillosis. In: Pasqualotto AC, ed. Aspergillosis: from diagnosis to prevention. New York: Springer; 2010:707–724
   Google Scholar
• Agarwal R, Chakrabarti A. Allergic bronchopulmonary aspergillosis in asthma: epidemiological, clinical and therapeutic issues. Future Microbiol 2013;8:1463–1474
   PubMed Web of Science ®Google Scholar
• Singh Sehgal I, Agarwal R. Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations. Eur Respir Rev 2014;23:149–152
   PubMedGoogle Scholar
• Kuiper L, Ruijgrok EJ. A review on the clinical use of inhaled amphotericin B. J Aerosol Med Pulm Drug Deliv 2009;22:213–227
   PubMed Web of Science ®Google Scholar
• Xia D, Sun WK, Tan MM, Zhang M, Ding Y, Liu ZC, Su X, Shi Y. Aerosolized amphotericin B as prophylaxis for invasive pulmonary aspergillosis: a meta-analysis. Int J Infect Dis 2015;30:78–84
   PubMed Web of Science ®Google Scholar
• Sehgal IS, Agarwal R. Role of inhaled amphotericin in allergic bronchopulmonary aspergillosis. J Postgrad Med 2014;60:41–45
   PubMed Web of Science ®Google Scholar
• Godet C, Goudet V, Laurent F, Le Moal G, Gounant V, Frat JP, Cateau E, et al. Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review. Mycoses 2015;58:173–180
   PubMed Web of Science ®Google Scholar
• Chishimba L, Langridge P, Powell G, Niven RM, Denning DW. Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA). J Asthma 2015;52:289–295
   PubMed Web of Science ®Google Scholar
• Agarwal R, Khan A, Garg M, Aggarwal AN, Gupta D. Pictorial essay: allergic bronchopulmonary aspergillosis. Indian J Radiol Imaging 2011;21:242–252
   PubMedGoogle Scholar
• Agarwal R, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A, Jindal SK. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients. Chest 2007;132:1183–1190
   PubMed Web of Science ®Google Scholar
• Agarwal R, Gupta D, Aggarwal AN, Saxena AK, Saikia B, Chakrabarti A, Jindal SK. Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis. Respir Med 2010;104:204–210
   PubMed Web of Science ®Google Scholar
• Agarwal R, Nath A, Aggarwal AN, Gupta D, Chakrabarti A. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India. Mycoses 2010;53:138–143
   PubMed Web of Science ®Google Scholar
• Agarwal R, Noel V, Aggarwal AN, Gupta D, Chakrabarti A. Clinical significance of Aspergillus sensitisation in bronchial asthma. Mycoses 2011;54:e531–e538
   PubMed Web of Science ®Google Scholar
• Agarwal R, Aggarwal AN, Garg M, Saikia B, Gupta D, Chakrabarti A. Allergic bronchopulmonary aspergillosis with aspergilloma: an immunologically severe disease with poor outcome. Mycopathologia 2012;174:193–201
   PubMed Web of Science ®Google Scholar
• Agarwal R, Garg M, Aggarwal AN, Saikia B, Gupta D, Chakrabarti A. Serologic allergic bronchopulmonary aspergillosis (ABPA-S): long-term outcomes. Respir Med 2012;106:942–947
   PubMed Web of Science ®Google Scholar
• Agarwal R, Khan A, Garg M, Aggarwal AN, Gupta D. Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis. World J Radiol 2012;4:141–150
   PubMedGoogle Scholar
• Agarwal R, Maskey D, Aggarwal AN, Saikia B, Garg M, Gupta D, et al. Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis. PLoS One 2013;8:e61105
   PubMed Web of Science ®Google Scholar
• Agarwal R, Aggarwal AN, Garg M, Saikia B, Chakrabarti A. Cut-off values of serum IgE (total and A. fumigatus-specific) and eosinophil count in differentiating allergic bronchopulmonary aspergillosis from asthma. Mycoses 2014;57:659–663
   PubMed Web of Science ®Google Scholar
• Agarwal R, Devi D, Gupta D, Chakrabarti A. A questionnaire-based study on the role of environmental factors in allergic bronchopulmonary aspergillosis. Lung India 2014;31:232–236
   PubMedGoogle Scholar
• Juniper EF, Bousquet J, Abetz L, Bateman ED. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire. Respir Med 2006;100:616–621
   PubMed Web of Science ®Google Scholar
• Proesmans M, Vermeulen F, Vreys M, De Boeck K. Use of nebulized amphotericin B in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. Int J Pediatr 2010;2010:376287
   PubMedGoogle Scholar
• Agarwal R, Khan A, Aggarwal AN, Gupta D. Is the SMART approach better than other treatment approaches for prevention of asthma exacerbations? a meta-analysis. Monaldi Arch Chest Dis 2009;71:161–169
   PubMedGoogle Scholar
• Agarwal R, Aggarwal AN, Sehgal IS, Dhooria S, Behera D, Chakrabarti A. Utility of IgE (total and A.fumigatus specific) in monitoring for response and exacerbations in allergic bronchopulmonary aspergillosis. Mycoses 2015;59:1–6
   PubMed Web of Science ®Google Scholar
• Greenberger PA. When oral corticosteroids are essential for persistent severe asthma. J Allergy Clin Immunol 2010;125:511–513
   PubMed Web of Science ®Google Scholar
• Agarwal R, Aggarwal AN, Dhooria S, Sehgal IS, Garg M, Saikia B, Behera D, Chakrabarti A. A randomized trial of glucocorticoids in acute stage of ABPA complicating asthma. Eur Respir J 2015; In Press. doi: 10.1183/13993003.01475-2015
   Google Scholar
• Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A, Bamberger DM, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000;342:756–762
   PubMed Web of Science ®Google Scholar
• Wark PA, Hensley MJ, Saltos N, Boyle MJ, Toneguzzi RC, Epid GD, Simpson JL, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003;111:952–957
   PubMed Web of Science ®Google Scholar
• Agarwal R. What is the current place of azoles in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. Expert Rev Respir Med 2012;6:363–371
   PubMed Web of Science ®Google Scholar
• Verweij PE, Ananda-Rajah M, Andes D, Arendrup MC, Bruggemann RJ, Chowdhary A, Cornely OA, et al. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. Drug Resist Updat 2015;2122:30–40
   Web of Science ®Google Scholar
• Moss RB. Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis. Eur Respir J 2014;43:1487–500
   PubMed Web of Science ®Google Scholar
• Marra F, Partovi N, Wasan KM, Kwong EH, Ensom MH, Cassidy SM, Fradet G, Levy RD. Amphotericin B disposition after aerosol inhalation in lung transplant recipients. Ann Pharmacother 2002;36:46–51
   PubMed Web of Science ®Google Scholar
• Monforte V, Roman A, Gavalda J, Lopez R, Pou L, Simo M, Aguadé S, et al. Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients. Transplantation 2003;75:1571–1574
   PubMed Web of Science ®Google Scholar
• Diot P, Rivoire B, Le Pape A, Lemarie E, Dire D, Furet Y, Breteau M, Smaldone GC. Deposition of amphotericin B aerosols in pulmonary aspergilloma. Eur Respir J 1995;8:1263–1268
   PubMed Web of Science ®Google Scholar
• Beyer J, Barzen G, Risse G, Weyer C, Miksits K, Dullenkopf K, Huhn D, Siegert W. Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis. Antimicrob Agents Chemother 1993;37:1367–1369
   PubMed Web of Science ®Google Scholar
• Beyer J, Schwartz S, Barzen G, Risse G, Dullenkopf K, Weyer C, Siegert W. Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis. Infection 1994;22:143–148
   PubMed Web of Science ®Google Scholar
• Casey P, Garrett J, Eaton T. Allergic bronchopulmonary aspergillosis in a lung transplant patient successfully treated with nebulized amphotericin. J Heart Lung Transplant 2002;21:1237–1241
   PubMed Web of Science ®Google Scholar
• Suzuki K, Iwata S, Iwata H. Allergic bronchopulmonary aspergillosis in a 9-year-old boy. Eur J Pediatr 2002;161:408–409
   PubMed Web of Science ®Google Scholar
• Tiddens HA, Pfaff SJ, van der Zan den T, Ruijgrok EJ. Weekly nebulization of liposomal amphotericine B for the treatment of prednisone dependent ABPA. Pediatr Pulmonol 2003;36:301
   PubMed Web of Science ®Google Scholar
• Laoudi Y, Paolini JB, Grimfed A, Just J. Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA? Eur Respir J 2008;31:908–909
   PubMed Web of Science ®Google Scholar
• Hayes D, Murphy BS, Lynch JE, Feola DJ. Aerosolized amphotericin for the treatment of allergic bronchopulmonary aspergillosis. Pediatr Pulmonol 2010;45:1145–1148
   PubMed Web of Science ®Google Scholar
• Godet C, Meurice JC, Roblot F, Kauffmann-Lacroix C, Verdaguer M, Frat JP, Cadranel J. Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA. Eur Respir J 2012;39:1261–1263
   PubMed Web of Science ®Google Scholar
• Casciaro R, Naselli A, Cresta F, Ros M, Castagnola E, Minicucci L. Role of nebulized amphotericin B in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis: case report and review of literature. J Chemother 2015;27:307–311
   PubMed Web of Science ®Google Scholar
• Ruijgrok EJ, Vulto AG, Van Etten EW. Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats. J Antimicrob Chemother 2001;48:89–95
   PubMed Web of Science ®Google Scholar